Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial
to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the
occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37
(Year 3) of study drug administration.